In January 2019, the US Food & Drug Administration (FDA) made an unprecedented call for an OTC Naloxone product. Why? Because every 6-7 minutes someone in America is dying from an opioid overdose – and the antidote Naloxone may not be at hand to save them.
But it should be.
Pocket Naloxone is answering that call for OTC Naloxone to remove the critical barriers that exist:
Millions of Americans are at risk of potentially suffering an opioid overdose. There is an urgent need for easy-to-use, low cost, OTC Naloxone. We consider it a privilege to try and play a role in addressing this aspect of the opioid crisis to potentially help prevent needless overdose deaths.